SCHEMBL31282074

SCHEMBL31282074

CCCCOC(=O)N1CC2(CC(CCO)C2)C1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ GBA2 Q9HCG7 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.35
▸ HRH2 P25021 1/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ ATM Q13315 1/20 0.33
▸ EPHX2 P34913 2/20 0.33
▸ NAAA Q02083 1/20 0.33
▸ GPR119 Q8TDV5 4/20 0.32
▸ BCHE P06276 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30063495 0.88 LMNA (0.43) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL29502235 0.86 LMNA (0.49) LMNAPOLBSMN1; SMN2GPR119
SCHEMBL23859720 0.82 LMNA (0.49) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30013395 0.81 LMNA (0.48) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30376526 0.81 LMNA (0.43) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL31365786 0.81 LMNA (0.43) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL29655416 0.81 LMNA (0.50) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30467459 0.80 LMNA (0.47) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL31532476 0.79 LMNA (0.41) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL18639389 0.79 LMNA (0.46) LMNAPOLBSMN1; SMN2GBA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731309-A1 KRAS PROTEOLYSIS TARGETING CHIMERAS Paq Therapeutics Inc. (US) 2026-04-29 — — EP disclosed
WO-2024263586-A1 KRAS PROTEOLYSIS TARGETING CHIMERAS PAQ Therapeutics Inc. (US) 2024-12-26 — — WO disclosed
Send feedback